Zheng Quan Zhi Xing·2025-09-02 00:09Group 1 - The core viewpoint is that two listed companies, Changchun High-tech and Kaiying Network, have recently been investigated by a well-known private equity firm, Licheng Asset, highlighting their advancements and financial performance [1][2]. Group 2 - Changchun High-tech has made significant progress in using AI large models to design highly alkaline single-domain antibodies, successfully completing the development of a protein product that has entered 5000-liter scale production [1]. - Kaiying Network reported a revenue of 2.578 billion yuan for the first half of 2025, a year-on-year increase of 0.89%, and a net profit attributable to shareholders of 950 million yuan, up 17.41% [2]. - The overseas revenue for Kaiying Network reached 202 million yuan, marking a substantial year-on-year growth of 59.57%, with multiple products topping overseas charts [2]. - Kaiying Network has launched an AI development platform named "SOON" and plans to introduce an AI toy brand "Warm Star Valley Dream Journey" in 2025 [2]. - The controlling shareholder of Kaiying Network has cumulatively increased their holdings by over 130 million yuan, and the Legend Box has attracted multiple enterprises, with payment amounts reaching 450 million yuan [2]. Group 3 - Licheng Asset is one of the earliest established private equity management companies in China, focusing on a growth stock investment philosophy with a complete and unique investment management knowledge system [3]. - The firm has a team of 50 employees, with nearly 30 being professional research and investment personnel, managing a peak scale of over 10 billion yuan, and specializing in secondary stock long strategies and PIPE strategies in the fields of pharmaceuticals, advanced manufacturing, and consumer goods [3]. - Licheng Asset has consistently ranked high in long-term performance and has received multiple private equity awards [3].